Reuters logo
23 天前
BRIEF-Pfizer says Besponsa approved in the EU for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia
2017年6月30日 / 中午11点53分 / 23 天前

BRIEF-Pfizer says Besponsa approved in the EU for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia

1 分钟阅读

June 30 (Reuters) - Pfizer Inc

* Besponsa® approved in the EU for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia

* Pfizer Inc - Prescription Drug User Fee Act (PDUFA) goal date for a decision by FDA is august 2017. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below